News

                        Array
(
    [0] => stdClass Object
        (
            [id] => 1417
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 800x600-web-1.png
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-03-19
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-03-19 08:42:43
            [updated_time] => 2026-03-24 15:16:17
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-will-present-at-the-workshop-advances-in-reproductive-medicine-13
            [title] => Eurofins GENTIS will present at the workshop “Advances in Reproductive Medicine 13”
            [description] => On March 28, 2026, at Melia Hanoi Hotel, the Hanoi Society for Reproductive Support will organize the scientific workshop “Advances in Reproductive Medicine 13” with the theme: “How to improve IVF cycle success rates.” This is one of the most important annual academic events in the field of reproductive support in Vietnam, attracting significant attention from doctors, scientists, embryologists, and healthcare managers in reproductive medicine.
            [content] => 
In the context of the increasing demand for infertility treatment, along with the rapid development of biotechnology and genetics, updating scientific advances and sharing practical experience in IVF (in vitro fertilization) treatment has become especially essential. The workshop “Advances in Reproductive Medicine 13” is organized to create a prestigious scientific forum where leading experts can discuss new trends, current challenges, and solutions to improve treatment outcomes in reproductive support.

An academic forum gathering leading experts in reproductive support
 According to the agenda, the workshop will include 4 in-depth scientific sessions focusing on key topics in current reproductive practice, including:
- Ovarian stimulation
- Genetics and new technologies in reproductive support
- Quality management in reproductive support
- Risk management and quality improvement
The discussion sessions are designed to provide a comprehensive perspective on factors affecting IVF success rates, from clinical strategies and advanced testing technologies to quality management systems and risk control in laboratories and reproductive centers.
In particular, the second session, themed “Genetics and new technologies in reproductive support,” is expected to deliver updated insights into the role of genetic testing techniques, sequencing technologies, and genetic applications in improving infertility treatment outcomes.
PhD Pham Dinh Minh to present on gene testing applications in IVF
 At Session 2: “Genetics and new technologies in reproductive support,” PhD Pham Dinh Minh – R&D Director of Eurofins GENTIS will present a report titled: “Enhancing IVF efficiency and success rates through gene testing and genetics.” The presentation will take place from 10:15 to 12:00 on March 28, 2026, at Melia Hanoi Hotel.
In recent years, gene testing techniques and genetic analysis have become an essential part of reproductive medicine. Advances in next-generation sequencing (NGS) and modern genetic analysis methods allow early detection of genetic abnormalities, enabling clinicians to make more precise treatment decisions.

The application of genetic testing in IVF can bring several benefits such as:
- Screening for chromosomal abnormalities in embryos
- Detecting hereditary diseases that may be passed to future generations
- Optimizing embryo selection for transfer
- Improving implantation potential and pregnancy success rates
Through this presentation, PhD Pham Dinh Minh will share the latest updates on genetic testing technologies in reproductive support and analyze how these methods can contribute to improving IVF treatment outcomes in clinical practice.
An experienced expert in genetics and omics sciences
 PhD Pham Dinh Minh is a scientist with many years of experience in Biochemistry, Omics sciences, Genetics, and medical testing. With over 10 years of experience in teaching and research, he has participated in numerous domestic and international scientific projects, making significant contributions to the development of biotechnology applications in medicine.
In terms of scientific publications, Dr. Minh is the author and co-author of more than 45 scientific papers, including over 23 articles published in international journals. His research focuses on applications of nanobiotechnology, genome analysis, and innovative technological solutions for disease diagnosis and treatment.
Additionally, Dr. Minh is the lead author of one book chapter and co-author of another chapter in a monograph on nanobiotechnology published by Wiley in 2023—one of the world’s most reputable scientific publishers.
In research activities, he is currently the principal investigator of one national-level project funded by Nafosted and two projects under the Ministry of Science and Technology related to nanobiotechnology and stem cells. He also serves as a key member in two international collaborative projects and two national-level projects.
Beyond research, Dr. Minh is actively involved in scientific training. He has supervised 1 PhD candidate, 5 master’s students, and 6 bachelor’s students, contributing to the development of the next generation of scientists in biotechnology and genetics.
Opportunities for knowledge update and professional networking
 The workshop “Advances in Reproductive Medicine 13” is expected to provide valuable scientific insights, helping doctors and specialists stay updated with the latest trends in reproductive medicine.
The participation of leading experts and in-depth presentations will create opportunities for delegates to exchange experiences, discuss clinical challenges, and explore solutions to improve IVF success rates.
For doctors, embryologists, and researchers in reproductive medicine, this is also an important occasion for professional networking, sharing practical experience, and accessing new technologies in infertility diagnosis and treatment.
With its highly practical theme and numerous specialized reports, the workshop promises to contribute to the development of reproductive support in Vietnam and open new approaches to enhance treatment effectiveness for patients.
We look forward to welcoming doctors and experts at the workshop “Advances in Reproductive Medicine 13” and encourage you not to miss the presentation by PhD Pham Dinh Minh on the application of gene testing and genetics in improving IVF outcomes.
            [content_more] => 
            [meta_title] => Eurofins GENTIS will present at the workshop “Advances in Reproductive Medicine 13”
            [meta_description] => On March 28, 2026, at Melia Hanoi Hotel, the Hanoi Society for Reproductive Support will organize the scientific workshop “Advances in Reproductive Medicine 13” with the theme: “How to improve IVF cycle success rates.” This is one of the most important an
            [meta_keyword] => Gentis,Hasar
            [thumbnail_alt] => 
            [post_id] => 1417
            [category_id] => 4
        )

    [1] => stdClass Object
        (
            [id] => 1416
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => huyen.8.2021/600x400-web-eurofins-gentis-x-xanh-sm.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-03-13
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-03-16 09:58:54
            [updated_time] => 2026-03-24 15:20:23
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 1
            [is_table_content] => 0
            [language_code] => en
            [slug] => Eurofins-GENTIS-x-Xanh-SM-Sustainable-health-green-mobility
            [title] => Eurofins GENTIS x Xanh SM: Sustainable health – green mobility
            [description] => In modern life, as healthcare needs are increasingly prioritized, choosing safe, convenient, and environmentally friendly transportation solutions has also become an important part of the journey. Understanding this, Eurofins GENTIS has partnered with Xanh SM to officially launch the campaign: Sustainable Health – Green Mobility, offering attractive incentives for customers using Xanh SM’s electric transport services to travel to Eurofins GENTIS and its partner clinics and hospitals nationwide.
            [content] => 

Green mobility – The starting point for a complete healthcare journey
 Medical check-ups, testing, and regular health monitoring are long-term investments in the future. However, many people may hesitate due to cost, time, and environmental impact. Through this campaign, Eurofins GENTIS collaborates with Xanh SM – Vietnam’s first fully electric transport brand – to deliver a smooth, safe travel experience while contributing to a cleaner environment for the community.
Eurofins GENTIS customers can access a variety of Xanh SM services, including Xanh SM Bike, Xanh SM Bike Plus, Xanh SM Car, Xanh SM Premium, and Xanh SM Limo, catering to all mobility needs from individuals to families.
Practical incentives for traveling to/from Eurofins GENTIS and partner hospitals
 As part of the campaign, customers traveling to or from Eurofins GENTIS and its partner hospitals and clinics will receive attractive discount codes of up to 20% on the Xanh SM app when selecting eligible pickup or drop-off points.

For new Xanh SM users, the program offers a 20% discount code with a maximum discount of VND 50,000, applicable across all services—from Xanh SM Bike and Xanh SM Bike Plus to Xanh SM Car, Xanh SM Premium, and Xanh SM Limo—making healthcare visits more convenient and cost-effective.
In addition, customers will receive extra service-specific offers, including two 15% discount codes (up to VND 40,000) for Xanh SM Bike and Xanh SM Bike Plus, and two 12% discount codes (up to VND 40,000) for Xanh SM Car, Xanh SM Premium, and Xanh SM Limo. These incentives enhance a green, safe, and flexible mobility experience throughout the healthcare journey.
Notably, discount codes will automatically appear in the “Promotions” section when customers select eligible Eurofins GENTIS locations or partner healthcare facilities, making redemption faster and more convenient than ever.

Additionally, customers who undergo NIPT testing at Eurofins GENTIS will receive one 20% discount code (up to VND 50,000) for nationwide travel. This code will be included in the leaflet attached to the hard-copy test result.
A nationwide network of destinations
 The campaign is available at Eurofins GENTIS offices in Hanoi and Ho Chi Minh City, along with a wide network of reputable hospitals and clinics such as Phenikaa University Hospital, Hanoi Andrology and Infertility Hospital, Hong Ngoc General Hospital, City International Hospital, Xuyen A General Hospital, and many other healthcare facilities across Hanoi, Ho Chi Minh City, Vinh Long, Tay Ninh, Long An, and Binh Duong.
This extensive network enables customers from various provinces to easily access high-quality genetic testing, consultation, and healthcare services while enjoying flexible green mobility incentives.
Joining hands for community health and a sustainable environment
 Beyond cost savings, the campaign reflects Eurofins GENTIS’s commitment to supporting customers in building a green – healthy – sustainable lifestyle. Every zero-emission electric ride is a small yet meaningful action that contributes to reducing air pollution and improving overall quality of life.
Eurofins GENTIS believes that when personal healthcare goes hand in hand with environmental protection, we are collectively creating a better future.
            [content_more] => 
            [meta_title] => Eurofins GENTIS x Xanh SM: Sustainable health – green mobility
            [meta_description] => In modern life, as healthcare needs are increasingly prioritized, choosing safe, convenient, and environmentally friendly transportation solutions has also become an important part of the journey. Understanding this, Eurofins GENTIS has partnered with Xan
            [meta_keyword] => XanhSM
            [thumbnail_alt] => 
            [post_id] => 1416
            [category_id] => 4
        )

    [2] => stdClass Object
        (
            [id] => 1415
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => 800x600-web.png
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2026-03-13
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-03-13 14:02:45
            [updated_time] => 2026-03-13 14:06:08
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-launches-PGT-FAST-Embryo-genetic-screening-solution-with-outstanding-turnaround-time
            [title] => Eurofins GENTIS launches PGT-FAST – Embryo genetic screening solution with outstanding turnaround time
            [description] => In recent years, advancements in assisted reproductive technologies have provided the opportunity for millions of couples worldwide to become parents. However, beyond creating embryos through in vitro fertilization (IVF), selecting embryos with good genetic quality remains a crucial factor in achieving successful pregnancies. Numerous studies have shown that chromosomal abnormalities in embryos are among the common causes of implantation failure, early miscarriage, or genetic syndromes in children after birth. Therefore, preimplantation genetic testing (PGT) has become increasingly important in modern IVF procedures. To support fertility centers in optimizing embryo selection, Eurofins GENTIS has launched a new test, PGT-FAST – an embryo genetic screening solution with the outstanding advantage of delivering results in just 15 hours.
            [content] => 

Comprehensive Chromosome Analysis for Embryo Genetic Screening
 PGT-FAST is a preimplantation genetic test performed before embryo transfer during IVF. By analyzing embryonic cells, the test evaluates the chromosomal status of embryos and detects abnormalities that may affect pregnancy development. The test allows for the analysis of all 24 chromosomes in the embryo, identifying numerical chromosomal abnormalities, also known as aneuploidy. These abnormalities can lead to serious genetic syndromes or prevent normal embryo development.
In addition, PGT-FAST can detect large structural chromosomal abnormalities, such as deletions or duplications of 5Mb or larger. These abnormalities may be associated with genetic syndromes that impact the health and development of the child. Embryo genetic screening provides fertility specialists with scientific evidence to select embryos with normal chromosomal complements, thereby increasing implantation rates and improving IVF treatment outcomes.
Significantly Reduced Turnaround Time
 One of the most notable features of PGT-FAST is its ability to significantly shorten analysis and reporting time. The optimized process allows results to be delivered within 15 hours from sample analysis. Rapid turnaround time offers practical benefits for both fertility centers and patients. Physicians can access embryo genetic results more quickly, enabling timely and appropriate clinical decisions during treatment. For many couples undergoing IVF, a shorter waiting period also helps reduce psychological stress and provides greater control over their treatment plan.
Application of Next-Generation Sequencing Technology
 PGT-FAST is based on Next Generation Sequencing (NGS), one of the most advanced and accurate genetic analysis technologies available today. The sequencing system used in this test is based on the Illumina platform (USA), combined with specialized genetic data analysis software, enabling highly accurate detection of abnormalities. The test achieves high sensitivity and specificity, ensuring reliable results for embryo genetic analysis. Utilizing modern analytical technologies not only improves test accuracy but also optimizes processes and reduces turnaround time.
The introduction of PGT-FAST represents another step forward in expanding Eurofins GENTIS’ genetic testing ecosystem in the field of assisted reproduction. This new testing solution is expected to provide fast, accurate, and efficient options for IVF centers and families seeking the opportunity to welcome healthy babies.
In an era where reproductive medicine increasingly emphasizes genetic factors, the development of advanced testing solutions like PGT-FAST is expected to further enhance treatment quality and help families move closer to their dream of becoming parents.
            [content_more] => 
            [meta_title] => Eurofins GENTIS launches PGT-FAST – Embryo genetic screening solution with outstanding turnaround ti
            [meta_description] => To support fertility centers in optimizing embryo selection, Eurofins GENTIS has launched a new test, PGT-FAST – an embryo genetic screening solution with the outstanding advantage of delivering results in just 15 hours.
            [meta_keyword] => GENTIS,PGT-FAST
            [thumbnail_alt] => 
            [post_id] => 1415
            [category_id] => 4
        )

    [3] => stdClass Object
        (
            [id] => 1414
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => z7616146207741_e7cffc3f616d1b8d7390f14ae1bddc50.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2026-03-13
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-03-13 13:33:19
            [updated_time] => 2026-03-13 16:35:38
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Eurofins-GENTIS-updates-PGT-FAST-and-GEN28-tests-at-Hanoi-General-Hospital-IVF-center
            [title] => Eurofins GENTIS updates PGT-FAST and GEN28 tests at Hanoi General Hospital IVF center
            [description] => Recently, a delegation of experts from Eurofins GENTIS, led by Dr. Nguyen Quang Vinh (Director of Eurofins GENTIS Testing Center), held a professional working session with the doctors and nurses of the Hanoi General Hospital Assisted Reproduction Center. This collaboration aims to update the latest advances in genetic testing, thereby contributing to improved treatment outcomes for families facing infertility. The session also opened opportunities for academic exchange and laid the groundwork for deeper cooperation between the two units in the future.
            [content] => 
The Eurofins GENTIS delegation was welcomed by MSc. MD. Nguyen Duy Phuong – Director of the Assisted Reproduction and Gender Medicine Center, along with doctors, nurses, and technicians from the hospital.

During the session, Pharmacist Duong Thi Phuong (Product Management Specialist at Eurofins GENTIS) presented an overview of PGT-FAST, the most advanced pre-implantation genetic screening test currently developed by Eurofins GENTIS. PGT-FAST is a pre-implantation genetic test performed before embryo transfer in the IVF process, helping assisted reproduction centers select embryos with high genetic quality. The test analyzes embryonic cells to assess genetic status and surveys all 24 chromosomes to detect chromosomal abnormalities (aneuploidy) – a common cause of implantation failure, early miscarriage, or genetic syndromes in newborns.
In addition, PGT-FAST can detect large structural chromosomal abnormalities such as deletions or duplications of 5Mb or more. The test is implemented using next-generation sequencing (NGS) technology on the Illumina platform, combined with advanced genetic data analysis software, ensuring high sensitivity, specificity, and accuracy in embryo genetic analysis.
A notable advantage of PGT-FAST is its rapid turnaround time, taking only about 15 hours from sample analysis to result. This allows doctors to access embryo genetic results quickly and make timely clinical decisions during the IVF cycle.
Alongside PGT-FAST, Pharmacist Phuong also introduced GEN28, a screening service for carriers of common genetic diseases. GEN28 screens 28 severe recessive genetic disease genes, detecting carriers even if they are completely healthy. The test uses NGS technology combined with advanced bioinformatics analysis to identify gene variants that may be passed to the next generation. With only 2–3 ml of whole blood, GEN28 can screen 28 genes associated with 25 genetic diseases and syndromes, including Thalassemia, G6PD deficiency, cystic fibrosis, Tay–Sachs disease, Wilson disease, galactose metabolism disorders, and more. These conditions can have serious, long-term impacts on health and quality of life.

Information on PGT-FAST and GEN28 received great attention from the medical team at Hanoi General Hospital IVF Center. Dr. Nguyen Quang Vinh directly answered many professional questions from the doctors. Additionally, Dr. Vinh emphasized Eurofins GENTIS’s commitment to continue applying advanced testing technologies and strengthening collaboration with assisted reproduction centers to improve patient service quality. At the conclusion of the session, MSc. MD. Nguyen Duy Phuong praised the expert team’s professional sharing and expressed the hope that both parties will continue to enhance cooperation in the future to provide more effective reproductive solutions for patients.
The session ended in an open and collaborative atmosphere. This event reaffirms Eurofins GENTIS’s commitment to delivering modern, accurate, and effective genetic testing solutions, contributing to increased opportunities for many Vietnamese families to become parents.

            [content_more] => 
            [meta_title] => Eurofins GENTIS updates PGT-FAST and GEN28 tests at Hanoi General Hospital IVF center
            [meta_description] => center
Recently, a delegation of experts from Eurofins GENTIS, led by Dr. Nguyen Quang Vinh (Director of Eurofins GENTIS Testing Center), held a professional working session with the doctors and nurses of the Hanoi General Hospital Assisted Reproduction 
            [meta_keyword] => GENTIS,PGT-FAST,GEN28
            [thumbnail_alt] => 
            [post_id] => 1414
            [category_id] => 4
        )

    [4] => stdClass Object
        (
            [id] => 1411
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => huyen.8.2021/600x400-web-eurofins-gentis-x-xanh-sm.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-02-03
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-02-09 13:18:40
            [updated_time] => 2026-02-27 13:50:39
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 1
            [is_table_content] => 0
            [language_code] => en
            [slug] => Travel-smarter-save-more-on-medical-visits-with-Eurofins-Gentis-and-Xanh-SM
            [title] => Travel smarter, save more on medical visits with Eurofins Gentis and Xanh SM
            [description] => To bring greater convenience and cost savings to customers traveling for medical check-ups and testing, Eurofins Gentis has partnered with the Xanh SM mobility app to launch a special promotion for customers commuting to Eurofins Gentis and its nationwide network of medical partners.

            [content] => 

Exclusive offers for Eurofins Gentis customers
Customers using the Xanh SM app to travel to Eurofins Gentis and partner locations will receive the following promo codes:

02 codes with 15% discount for Xanh SM Bike and Xanh SM Bike Plus services
02 codes with 12% discount for Xanh SM Car, Xanh SM Car Premium, and Xanh SM Limo services
New Xanh SM users receive an additional 20% discount code


In addition, customers who undergo the NIPT prenatal screening test at Eurofins Gentis will receive 01 extra 20% discount code, applicable for nationwide travel with a maximum discount of VND 50,000. The promo code will be included in the leaflet attached to the hard-copy test result.
How to receive and use the promo codes
Getting your discount is simple:

Open the Xanh SM app.
Enter your pick-up location and destination as Eurofins Gentis or one of its partner facilities.
The promo codes will automatically appear in the “Promotions” section.
Select the applicable code and proceed with your ride booking.


17 participating locations under the Eurofins Gentis program

Andrology and fertility hospital of Hanoi
The Vietnam-Belgium Andrology & Infertility Specialist hospital
Phenikaa University hospital
Hong Ngoc general hospital
Hong Ngoc - Phuc Truong Minh general hospital
Bao Son general hospital
Hanoi general hospital
Phuong Dong general hospital
An Viet general hospital
Dong Do hospital
Vietnam’s premier medical 
Hanh Phuc international hospital
Saigon Reproductive Medicine and Andrology hospital
Pham Nhat Infertility and IVF Clinic
City international hospital 
Xuyen A general hospital

Supporting your healthcare journey
Through the collaboration between Eurofins Gentis and Xanh SM, customers can feel confident not only in the quality of medical services but also in receiving optimal transportation support—making medical visits and testing more convenient, cost-effective, and stress-free.
Book your Xanh SM ride today and experience smart mobility when visiting Eurofins Gentis and its trusted medical partners.
            [content_more] => 
            [meta_title] => Travel smarter, save more on medical visits with Eurofins Gentis and Xanh SM
            [meta_description] => To bring greater convenience and cost savings to customers traveling for medical check-ups and testing, Eurofins Gentis has partnered with the Xanh SM mobility app to launch a special promotion for customers commuting to Eurofins Gentis and its nationwide
            [meta_keyword] => GENTIS,XanhSM
            [thumbnail_alt] => 
            [post_id] => 1411
            [category_id] => 4
        )

    [5] => stdClass Object
        (
            [id] => 1410
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => banner/600x400-web-banner-thang-genneva-2.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-02-02
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-02-09 10:33:53
            [updated_time] => 2026-02-27 13:50:48
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 1
            [is_table_content] => 0
            [language_code] => en
            [slug] => Prosperous-Tet-auspicious-deals-with-GenEva-Enjoy-up-to-VND-3,000,000-in-benefits-for-expecting-mothers
            [title] => Prosperous Tet – auspicious deals with GenEva: Enjoy up to VND 3,000,000 in benefits for expecting mothers
            [description] => On the occasion of welcoming the Lunar New Year 2026, Eurofins Gentis would like to extend our warmest wishes of health, peace, and a fulfilling pregnancy to all expecting mothers and their families. With the desire to accompany mothers on a healthy pregnancy journey, GenEva is launching a special early-year promotion with total benefits of up to VND 3,000,000 for customers who register for the non-invasive prenatal screening (NIPT) test.
            [content] => 

GenEva new year promotion details
During the promotional period, mothers who register for the GenEva NIPT test will enjoy attractive incentives—helping reduce costs while ensuring international-standard testing quality from Eurofins Gentis.
Receive up to VND 3,000,000 in cash incentives when booking:

9 Autosomal Recessive Single-Gene Disease Screening Package
18 Autosomal Recessive Single-Gene Disease Screening Package

(Incentives are applied correspondingly to each testing package.)
⏰ Promotion period: From January 26, 2026, until further notice.
 Early registration is encouraged as promotional slots are limited.
This program applies to customers who book within the promotional period, subject to availability.
The offer aims to support expectant mothers in accessing advanced prenatal screening services early—empowering them to proactively monitor and manage pregnancy health from the very first stages.
Why choose GenEva NIPT?
GenEva non-invasive prenatal testing (NIPT) analyzes cell-free fetal DNA present in the mother’s blood to assess the risk of common chromosomal abnormalities.

Safe for both mother and baby
Non-invasive procedure
High accuracy

GenEva is implemented at Eurofins Gentis with a rigorous testing process, an experienced team of experts, and internationally accredited laboratory systems.
Eligible participants
The GenEva New Year 2026 promotion applies to pregnant women who wish to undergo NIPT prenatal screening and register for the service within the promotional period in accordance with Eurofins Gentis’ terms and conditions.
How to register and receive the promotion
For detailed consultation and to book your GenEva NIPT test, please contact our hotline at 0988 00 2010. The Eurofins Gentis expert team is ready to assist mothers in selecting the most suitable testing package and guide them through a quick and convenient process.


            [content_more] => 
            [meta_title] => Prosperous Tet – auspicious deals with GenEva: Enjoy up to VND 3,000,000 in benefits for expecting m
            [meta_description] => On the occasion of welcoming the Lunar New Year 2026, Eurofins Gentis would like to extend our warmest wishes of health, peace, and a fulfilling pregnancy to all expecting mothers and their families. With the desire to accompany mothers on a healthy pregn
            [meta_keyword] => GENTIS,NIPT
            [thumbnail_alt] => 
            [post_id] => 1410
            [category_id] => 4
        )

    [6] => stdClass Object
        (
            [id] => 1409
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => banner/600x400-web--banner-thang-2.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 1
            [displayed_time] => 2026-02-02
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-02-09 10:26:42
            [updated_time] => 2026-02-27 13:50:56
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 1
            [is_table_content] => 1
            [language_code] => en
            [slug] => New-Year-2026-promotion-20%-off-all-DNA-testing-services-at-Eurofins-Gentis
            [title] => New Year 2026 promotion – 20% off all DNA testing services at Eurofins Gentis
            [description] => At the beginning of 2026, Eurofins Gentis is launching a special promotion offering 20% off all DNA testing services, providing customers with a cost-saving opportunity to access internationally standardized, accurate, and confidential DNA testing services.
            [content] => 
On the occasion of the New Year, Eurofins Gentis sincerely wishes our valued customers good health, prosperity, and happiness. We deeply appreciate your continued trust and companionship over the years. As we enter 2026, Eurofins Gentis remains committed to enhancing service quality and delivering accurate, scientific, internationally accredited DNA testing solutions that help protect the health and family values of Vietnamese families.
As a token of appreciation, Eurofins Gentis is pleased to offer 20% off all DNA testing services.
The promotion is valid from January 26, 2026, until further notice, with priority given to early registrations. To receive the offer, customers may contact the hotline 0988.00.2010 for consultation and appointment scheduling.

List of discounted DNA testing services
Eurofins Gentis provides a wide range of DNA testing services to meet different customer needs:
Voluntary DNA testing

Paternity and maternity testing
Sibling testing (half-siblings, full siblings)
Paternal lineage testing (grandfather–grandchild, uncle–nephew/niece, etc.)
Maternal lineage testing


Legal DNA testing

Birth certificate support
Determination of child support obligations after divorce
Relationship confirmation for inheritance and other legal procedures
Identification of biological relationships to reconnect with family members

Non-Invasive prenatal DNA testing (NIPT)
This service is also eligible for the 20% discount, with fast turnaround time—typically within 7–10 days.
Sample collection options
Customers may choose one of the following sample submission methods:

Schedule home sample collection via hotline (available from Da Nang northward).
Self-collect samples and send them to Gentis Testing Center at:
 3rd Floor, V+ Commercial Center, 505 Minh Khai, Vinh Tuy, Hanoi.
Visit the Gentis Testing Center directly for staff-assisted sample collection.

Accepted sample types include blood, buccal swabs (oral mucosa), hair with roots, fingernails/toenails, umbilical cord samples, and special samples such as teeth, cigarette butts, toothbrushes, chewing gum, clothing, and more.
Important notes when registering
The promotion applies to customers who register online and is available for a limited time. To enjoy the 20% discount on all DNA testing services, customers are encouraged to contact Eurofins Gentis early for detailed consultation and step-by-step guidance on the testing process.
Start the New Year with confidence and peace of mind—let Eurofins Gentis accompany you in protecting your family’s truth and future.

            [content_more] => 
            [meta_title] => New Year 2026 promotion – 20% off all DNA testing services at Eurofins Gentis
            [meta_description] => At the beginning of 2026, Eurofins Gentis is launching a special promotion offering 20% off all DNA testing services, providing customers with a cost-saving opportunity to access internationally standardized, accurate, and confidential DNA testing service
            [meta_keyword] => ADN
            [thumbnail_alt] => 
            [post_id] => 1409
            [category_id] => 4
        )

    [7] => stdClass Object
        (
            [id] => 1408
            [id_crawler] => 
            [category_product] => NULL
            [thumbnail] => c297db27af2f2171783e.jpg
            [album] => 
            [url_video] => 
            [is_status] => 1
            [is_featured] => 0
            [is_form] => 0
            [displayed_time] => 2026-02-06
            [program] => 0
            [number] => 1
            [viewed] => 0
            [type] => 
            [type_career] => 
            [level] => 
            [address] => 
            [address_career] => 
            [expiration_time] => 0000-00-00
            [created_time] => 2026-02-06 09:54:55
            [updated_time] => 2026-02-27 13:51:10
            [files] => 
            [salary] => 
            [time] => 
            [created_by] => 63
            [is_table_content] => 1
            [language_code] => en
            [slug] => Summary-of-5-hereditary-cancer-testing-packages-at-Eurofins-GENTIS
            [title] => Summary of 5 hereditary cancer testing packages at Eurofins GENTIS
            [description] => Cancer is one of the leading causes of death worldwide. Numerous studies indicate that 5–10% of cancer cases are associated with hereditary factors, resulting from gene mutations that can be passed down from one generation to the next. Hereditary cancer testing helps identify risks early, enabling the development of appropriate monitoring, prevention, and medical intervention strategies.
            [content] => 
Understanding the growing demand for genetic screening in the community, Eurofins GENTIS has developed five hereditary cancer testing packages ranging from basic to advanced levels, tailored to different individuals, age groups, and family histories.
Why consider hereditary cancer testing?
Unlike conventional tests that detect cancer after it develops, hereditary cancer testing focuses on genetic analysis to determine cancer risk before clinical symptoms appear.
Key benefits include:

Early detection of potential hereditary cancer risks
Proactive development of personalized screening plans
Support for physicians in prevention and treatment counseling
Provision of valuable genetic information for family members
Reduced psychological burden through better understanding of personal health risks


With internationally standardized laboratories and an experienced team of genetic experts, Eurofins GENTIS delivers accurate, reliable testing solutions tailored to the Vietnamese population.

Summary of 5 hereditary cancer testing packages at Eurofins GENTIS
LADY - CARE: Hereditary cancer testing package for women
LADY - CARE is specifically designed for women, focusing on cancers with high incidence rates and strong hereditary associations.

Analysis of 10 genes
Screening for hereditary breast cancer, ovarian cancer, and colorectal cancer


Suitable for:

Women with a family history of breast, ovarian, or colorectal cancer
Women who wish to proactively assess hereditary cancer risk
Women of reproductive or middle age


LADY - CARE helps women better understand their genetic risks and develop appropriate medical monitoring and intervention plans to enhance quality of life.

MEN - CARE: Hereditary cancer screening solution for Men
Men also face various cancers influenced by hereditary factors, particularly prostate and gastrointestinal cancers.

Analysis of 10 genes

Screening for hereditary prostate cancer, colorectal cancer, and gastric cancer


Suitable for:

Men with a family history of related cancers

Middle-aged men or those with high-risk lifestyles or environmental exposures

Individuals seeking proactive genetic health screening


MEN - CARE is an important step in early cancer risk detection, enabling long-term prevention and medical follow-up.

PRE - CARE: Expanded screening for 15 hereditary cancers
PRE - CARE is an extended hereditary cancer testing package for individuals seeking more comprehensive risk assessment.

Analysis of mutations in 17 genes
Screening for 15 hereditary cancers, including: lung, stomach, breast, ovarian, colorectal, pancreatic, kidney, prostate, thyroid, skin, endometrial cancers, paraganglioma, retinoblastoma, pheochromocytoma, and multiple endocrine neoplasia


Suitable for:

Individuals with family histories of multiple cancer types
Those seeking expanded hereditary cancer screening
Individuals planning marriage or childbirth



PRO - CARE: Advanced hereditary cancer testing package
PRO - CARE provides a comprehensive overview of hereditary cancer risks.

Analysis of mutations in 133 genes

Screening for 30 hereditary cancers, including: lung, stomach, breast, ovarian, colorectal, pancreatic, kidney, prostate, thyroid, skin, endometrial, liver, bladder, head and neck, esophageal, biliary tract, small intestine, brain, bone, parathyroid cancers; acute leukemia (blood cancer); rhabdomyosarcoma; pituitary adenoma; neuroblastoma; neurofibroma; and multiple myeloma


Suitable for:

Individuals at high risk of cancer
Families with multiple affected members
Those requiring comprehensive genetic evaluation for long-term monitoring



DIAMOND - CARE: The most comprehensive genetic testing package
DIAMOND - CARE is the most advanced and comprehensive package at Eurofins GENTIS, combining hereditary cancer screening with inherited chronic disease testing.

Total analysis of 177 genes associated with 69 hereditary chronic diseases and cancers, including:



 10 genes – 9 common autosomal recessive disorders:
 Alpha Thalassemia, Beta Thalassemia, G6PD deficiency, Phenylketonuria (PKU), Galactose metabolism disorder, Citrin deficiency–related cholestasis, 5-Alpha Reductase deficiency–related male sex development disorder, Pompe disease, Wilson disease
 133 genes – Screening for 30 hereditary cancers (entire PRO - CARE panel)
 34 genes – 30 hereditary syndromes and chronic conditions:
 20 cardiovascular diseases, 5 connective tissue disorders, and 5 endocrine–metabolic disorders

DIAMOND - CARE is especially suitable for individuals seeking a comprehensive evaluation of hereditary health risks for themselves and their families.
With advanced gene sequencing technology, strict quality control processes, and a highly experienced team of experts, Eurofins GENTIS is committed to delivering accurate, reliable, and clinically valuable results.
Hereditary cancer testing is not just a test — it is a proactive step toward early prevention, appropriate monitoring, and personalized healthcare.
Contact Eurofins GENTIS via hotline 1800 2010 for detailed consultation and to choose the most suitable testing package for you and your family.

            [content_more] => 
            [meta_title] => Summary of 5 hereditary cancer testing packages at Eurofins GENTIS
            [meta_description] => Cancer is one of the leading causes of death worldwide. Numerous studies indicate that 5–10% of cancer cases are associated with hereditary factors, resulting from gene mutations that can be passed down from one generation to the next. Hereditary cancer t
            [meta_keyword] => GENTIS,genetic disorder
            [thumbnail_alt] => 
            [post_id] => 1408
            [category_id] => 4
        )

)